Unity Looks Ahead To Pivotal Study With Positive DME Data For UBX1325

 
• By Alaric DeArment
  
Unity Biotechnology announced data from the Phase II BEHOLD trial in DME • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D